CompletedPhase 2NCT01797432

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Maria Hordinsky, MD
University of Minnesota - Department of Dermatology
Intervention
Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10)(drug)
Enrollment
14 enrolled
Eligibility
18 years · All sexes
Timeline
20092015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01797432 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials